15 - 17 October, 2012
The Ritz Carlton, Laguna Niguel, CA

Thanks to our BioNetwork West 2011 Sponsors

 

AriVan Research LLC (AVR) is a specialized consulting firm that works closely with biopharmaceutical, diagnostic and medical device clients to augment BD&L activities. Essentially, our expertise involves conducting in-depth primary research with KOLs, clinical investigators, healthcare company personnel, payers, and other industry sources to address important BD-related questions and issues. A thorough analysis of secondary and/or audit data may be completed as well. From there, our highly-experienced group of MBAs, MDs & PharmDs analyzes the information to provide rational and insightful recommendations. In fact, the combination of exhaustive primary research methodologies, secondary data interpretation and in-depth analysis by industry professionals distinguishes AVR from many other consulting firms. Among other assignments, AVR has successfully completed proprietary engagements to: identify and validate in-licensing candidates; analyze co-promotion opportunities; assess acquisition targets; evaluate new market opportunities (including white space evaluations); investigate new technologies; and elicit payer perceptions on new products and services. AVR maintains strong capabilities across many disease categories -- including but not limited to oncology, cardiology, endocrinology, infectious disease, immunology, pain, neurology, psychiatry, and gastroenterology. AVR's ultimate goal: provide critical information and compelling insights to ensure our clients' success in the marketplace. 

Please visit us at www.arivanresearch.com.

    

Campbell Alliance is the leading management consulting firm specializing in the pharmaceutical and biotechnology industry. The firm's clients include most of the world's top-20 pharmaceutical companies, as well as numerous emerging and midsize firms. Campbell Alliance is organized into practice areas, each specializing in a critical industry function: Brand Management, Business Development, Clinical Development, Pricing and Market Access, Medical Affairs, and Sales. From its locations in Raleigh, NC, Parsippany, NJ, Los Angeles, San Francisco, Chicago, Boston, Philadelphia, New York City, and Zug, Switzerland, the firm serves clients throughout North America, Europe, and Japan. For more information on Campbell Alliance, please visit http://www.campbellalliance.com.

    

Dean & Company is a strategy consulting firm with a unique mix of both traditional business strategy work and a range of investing activities for large corporations, technology start-ups, and private equity funds. In Life Sciences, we work with both the largest global companies as well as emerging leaders in the Pharmaceuticals, Biotechnology, and Medical Devices industries, and have developed specialized expertise in the Vaccines industry. Our life sciences capabilities extend across a wide range of industry challenges and issues: Portfolio/BD Strategy, Life Cycle Management, Licensing/M&A, TA Opportunity Assessment, Target Identification/Valuation, Divestiture Support, Product Commercialization & Launch, Competitive Intelligence, and Manufacturing & Distribution Strategy. We have formed a partnership with Corporate Value Associates (CVA), who with fourteen offices in Europe, Australia, China, Korea, and Japan, provide us with on-the-ground resources to serve our global clients.

    

EvaluatePharma® is the premier source for commercial analysis of the pharma and biotech sector. The research company EvaluatePharma is the leading supplier of reliable consensus forecasts for prescription sales and now provides standardised worldwide financial and product forecast models, plus extensive coverage of R&D pipelines, licensing deals, patent risk and M&A activity. Our expertise and innovative approach to data analysis has led to other pioneering developments including the Calendar of Events and EventAnalyzer, and a fully interactive NPV Analyzer, joined by enhanced sales forecasting by indication, and unique analysis of licensing opportunities, clinical trials worldwide, and venture financing rounds.

    

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP With more than 375 intellectual property lawyers, Finnegan is one of the largest IP law firms in the world. From offices in the United States, Europe, and Asia, we work with leading innovators to protect, advocate, and leverage their most important IP assets. We handle all aspects of patent, trademark, copyright, and trade secret law, including counseling, prosecution, licensing, and litigation, with particular experience in Abbreviated New Drug Application (ANDA) and biotechnology cases. Our Biotechnology/Pharmaceutical Practice Group includes 86 professionals, many of whom hold advanced degrees and have substantial research experience. In addition, 63 members of the group are registered to practice before the U.S. Patent and Trademark Office, and five are former patent examiners. We represent branded clients of every size and in a wide range of biotechnology and pharmaceutical specialty areas—from new ventures safeguarding their first revolutionary idea to global corporations owning some of the largest and most valuable IP portfolios. Through our work, we have first-hand experience in cutting-edge advances such as genomics, immunology, nanotechnology, proteomics, transgenics, virology, sustained-released drug formulations, and new chemical entities (NCEs). For more information, please visit www.finnegan.com

    

IntraLinks® provides enterprise-class solutions which facilitate the secure, compliant and auditable exchange of critical information, collaboration and workflow management inside and outside the enterprise. Our on-demand solutions help you organize, manage, share and track information, enabling you to accelerate your workflow, optimize your business processes and realize new profit potential. Since 1997, IntraLinks has been used on critical business processes by more than 750,000 users from 90,000 organizations worldwide, including 10 of the top 10 pharmaceutical companies and hundreds ofbiotechs. IntraLinks counts 800 of the Fortune 1000 as clients, including enterprises such as AstraZeneca Pharmaceuticals LP, Bank of America, Deutsche Bank and the FDIC. For more information, visit www.intralinks.com

    

Sanofi-Aventis, a leading global pharmaceutical company, discovers, develops, and distributes therapeutic solutions to address the world's expanding healthcare needs. We work to prevent and treat the diseases that we know of today, as well as those we may face tomorrow. With approximately 100,000 dedicated professionals in more than 100 countries, sanofi-aventis is devoted to advancing healthcare around the world. We are committed to maintaining the innovative approach to pharmaceuticals established by our parent company, headquartered in Paris, France. Our U.S. affiliate, with headquarters in Bridgewater, New Jersey, employs approximately 15,000 professionals located throughout the country. Sanofi-aventis, U.S. is a dynamic healthcare organization working to meet the needs of physicians and their patients. At sanofi-aventis, each and every day we work for what really matters: health.

    

Deloitte Recap LLC

Deloitte Recap LLC (member of Deloitte Touche Tohmatsu Limited) provides products, consulting and advisory services focusing on Biopharma alliance deals and clinical development. The Recap IQ database products provide critical information on alliances and clinical developments within the industry. Deloitte Recap has a database of over 35,000 pharma/biopharma deals including many with unredacted contracts to use as a reference for business development professionals structuring their own deals. Deloitte Recap's customers include pharma, biotech, government agencies, academia, law firms, private financing companies and financial services companies.

    

Morrison & Foerster

Morrison & Foerster is an international firm with more than 1,000 lawyers across 15 offices in the U.S., Europe, and Asia. Founded in 1883, we remain dedicated to providing our clients, which include technology and life science companies, financial institutions and Fortune 100 companies, with legendary service. Clients rely on us for innovative and business-minded solutions. Our attorneys share high standards, a commitment to excellence, and a passion for helping their clients succeed. This commitment to serving client needs has resulted in enduring relationships and a record of high achievement. We are also recognized for our long-standing commitment to pro bono work and diversity.

Our 130 dedicated life sciences lawyers are recognized for their comprehensive legal services to clients around the world. From concept to commercialization through exit, we serve life sciences companies, research institutions, and the venture capital funds and investment banks that finance them. Our life science attorneys are called upon to assist in all phases and kinds of financings, technology transactions, licensing and strategic collaborations, mergers and acquisitions, patent counseling, patent prosecution, patent diligence, and intellectual property litigation. We also counsel life sciences clients in the areas of product liability, employment and labor, tax, and restructuring.

    

Foley Hoag

Foley Hoag is a dynamic law firm that represents public and private clients in a wide range of disputes and transactions worldwide. We have expertise in industries such as life sciences and healthcare, technology and professional services. Our life sciences practice understands the competitive, regulatory and litigation challenges that arise when developing and introducing new products and technologies to the global marketplace. Our lawyers are ready to help overcome these obstacles. From initial conception to commercial viability, from market success to expansion, we provide our clients with strategic and practical legal advice that is tailored to each of our clients' unique goals. We are former scientists, engineers, researchers, physicians, and political advisors. With these backgrounds and experiences, we bring diversity and depth of knowledge to clients ranging from manufacturers of medical devices and biotech or pharmaceutical products to leading research institutions and major industry advocacy organizations. From our offices in Boston, Washington, D.C. and Paris, and our Emerging Enterprise Center in Waltham, Massachusetts, Foley Hoag combines powerful regional, national and international practices that share a common emphasis on client service. We are focused on what we do best: helping our clients succeed through the delivery of exceptional legal service. For more information, visit www.foleyhoag.com.

    

GLG Research

GLG Research partners with organizations seeking efficient, targeted connections to insights. We provide access to primary research for a wide range of companies: financial and investment institutions, life science companies, the Fortune 1000 and entrepreneurs around the globe. Our extensive and rigorous compliance framework improves our clients' best practices while we connect them to the most relevant insights.

For more information on GLG Research, please visit www.gersonlehrmangroup.com

    

Gryphon Scientific

Gryphon Scientific is a specialized, small business consulting practice comprised of life scientists, health researchers, and accomplished BioPharma executives who apply rigorous scientific analysis to problems of global health and commercial strategy. Leveraging our best-in-class staff experience, technology, and capability, we provide evidence-based commercial strategy and decision support for the most successful biotech, pharmaceutical, and device companies globally. Over the last six years, our projects have influenced life science policy changes at the highest levels of US government as well as success of several billion dollars of healthcare brands. Our goal is to prepare our clients to reveal and maximize the value of their assets.

Working closely with executives, boards, and investors, Gryphon Scientific's Commercial Strategy team delivers evidence-based recommendations to reveal the reality of an asset's value proposition. We leverage capabilities in research, modeling, simulation, competitive intelligence, and large scale data analytics to provide empirical and transparent answers to our clients critical business questions. Examples of our support include:
• Market potential and pricing/payor strategy
• Business development and due diligence support
• Search, submission, acquisition, administrative support for sources of non-dilutive capital
• Trial, publication, and launch planning for Phase 3 products and beyond
• Commercial effectiveness, marketing innovation and optimization


Theme2 Master Page Theme2 PageName:aboutoursponsors.aspx EventInfo Id = 138050 Content Id = 138154 Content Title = AboutOurSponsors